StonvexLoading…
StonvexStonvexStonvexCore line items from LILA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.08B | $4.44B | $3.28B | $2.17B |
Operating Income | $145.20M | $108.20M | $-17.40M | $-204.90M |
Net Income | $-22.70M | $-611.20M | $-556.40M | $-559.70M |
EPS (Diluted) | $-0.11 | $-3.06 | $-2.79 | $-2.82 |
Total Assets | $12.16B | $12.23B | $12.05B | $11.95B |
Total Liabilities | $11.15B | $11.16B | $10.89B | $10.83B |
Cash & Equivalents | $681.40M | $783.90M | $596.70M | $514.40M |
Free Cash Flow OCF − CapEx | $-57.10M | $305.90M | $-14.20M | $-70.20M |
Shares Outstanding | 200.30M | 199.50M | 199.20M | 198.70M |